Image credit: Aphria

Aphria Reports a Second Consecutive Profitable Quarter, While Some Investors Share Concern Over Canadian Market

During an earnings call on Tuesday, Aphria emphasized Canadian growth opportunities against what some investors see as a disappointing first year of adult-use sales in the country.

Business
New York

New York: Cannabis and the Cuomo Effect

While Cuomo’s scandals might have helped push legalization over the finish line in 2021, the latest fallout could cause delays in setting up the industry.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.